Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Kemox Cellulose Co., Ltd., known as Kemox, is a leading manufacturer specializing in cellulose ether products, including Hydroxypropyl Methylcellulose (HPMC) and Hydroxyethyl Cellulose (HEC). While the company serves diverse industries such as construction and coatings, it is a significant supplier to the pharmaceutical and food sectors, providing high-quality excipients used in tablet coatings, controlled-release formulations, and capsule manufacturing. Kemox operates advanced manufacturing facilities in China and focuses on R&D to improve the performance of polymer additives. Their pharmaceutical-grade products are designed to meet international standards for drug delivery and stability. The company maintains a global distribution network, supporting pharmaceutical formulation needs across various international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kemox Cellulose.